Access Bio Dividends and Buybacks

Dividend criteria checks 0/6

Access Bio does not currently pay a dividend.

Key information

0%

Dividend yield

-0.3%

Buyback Yield

Total Shareholder Yield-0.3%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio0%

Recent dividend and buyback updates

Recent updates

What Access Bio, Inc.'s (KOSDAQ:950130) 28% Share Price Gain Is Not Telling You

May 22
What Access Bio, Inc.'s (KOSDAQ:950130) 28% Share Price Gain Is Not Telling You

Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 26% But Growth Is Lacking

Jan 06
Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 26% But Growth Is Lacking

Access Bio, Inc.'s (KOSDAQ:950130) Prospects Need A Boost To Lift Shares

Nov 13
Access Bio, Inc.'s (KOSDAQ:950130) Prospects Need A Boost To Lift Shares

Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking

Aug 07
Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking

Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Mar 26
Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Is Access Bio (KOSDAQ:950130) A Risky Investment?

Mar 25
Is Access Bio (KOSDAQ:950130) A Risky Investment?

If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Feb 18
If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A950130's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A950130's dividend payments have been increasing.


Dividend Yield vs Market

Access Bio Dividend Yield vs Market
How does A950130 dividend yield compare to the market?
SegmentDividend Yield
Company (A950130)0%
Market Bottom 25% (KR)1.1%
Market Top 25% (KR)3.6%
Industry Average (Medical Equipment)0.8%
Analyst forecast (A950130) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A950130's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A950130's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: A950130 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A950130 has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/20 09:45
End of Day Share Price 2025/06/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Access Bio, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jongsun ParkEugene Investment & Securities Co Ltd.
Gwang Sik ParkKyobo Securities Co., Ltd
Kyung-Churl NohSK Securities Co., Ltd.